Author
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of December 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of November 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of September 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of August 2021.
Topics range from issues related to FDA’s approval of aducanumab, to an analysis of the communication of survival data in cancer drug labels.
